Phase 1 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD): Safety, Tolerability, and Target Engagement (1557)
暂无分享,去创建一个
L. Ronco | B. Engelen | D. Cadavid | G. Groeneveld | L. Thompson | M. Mellion | S. Raines | L. Pagan | S. Brooks | M. Hage | U. Badrising | W. Tracewell | E. V. Brummelen